September 18, 2008
Visensia Summit for Patient Safety Brings Together Healthcare Leaders
OBS Medical hosted its first-ever Visensia(R) Summit on September 8. It welcomed key leaders in patient safety to its hometown of Indianapolis. Nurses, physicians and administrators that use and/or support Visensia had the opportunity to meet and learn from each other's experiences while actively participating in its exciting growth.
Formerly known as BioSign, Visensia fuses up to five vital signs - heart rate, respiration rate, body temperature, oxygen saturation and blood pressure - into a numerical index, the Visensia Index. This Index is an indication of a patient's wellness and enables significant improvement in clinical outcome and optimization of hospital resource utilization.
The day began with a welcome by CEO Frank Cheng and was followed by Clarian Health CEO & President Daniel F. Evans, Jr. who spoke about patient safety challenges and opportunities. The keynote speaker was Dr. Michael R. Pinsky, professor and vice chairman of Academic Affairs in the Department of Critical Care Medicine at the University of Pittsburgh Medical Center (UPMC). He presented on "Rapid Response Systems and the Use of Electronic Integrated Monitoring" and shared findings from a large UPMC study and peer-reviewed paper published in Archives of Internal Medicine - "Defining the Incidence of Cardiorespiratory Instability in Patients in Step-down Units Using an Electronic Integrated Monitoring System". Involving 1,000 patients (18,248 hours of continuous monitoring in Phase I), the study became the largest ever continuous monitoring study for cardiorespiratory variables in non-ICU patients. This new evidence strongly supports Visensia's ability to detect clinical instability early and thereby avert a clinical crisis.
The nurses' round table was hosted by Lisbeth Vortuba, RN, MSN of St. Mary's Health Care, Marilyn Hravnak, RN, PhD and Leslie Edwards, BSN, CMSRN both from UPMC. The discussion focused on workflow and implementation. Additional user feedback, best practices and anecdotes were also shared. OBS Medical provided insight into future research and development, feature expansions, and implementation opportunities.
Summit attendees were from Clarian Health, University of Pittsburgh Medical Center, Saint Mary's Health Care, Saint Joseph Mercy Oakland, Parkview Health, Bloomington Hospital, Community Health Network, Allegheny General Hospital, Saint Joseph's, Brigham and Women's Hospital and Borgess Health.
About OBS Medical
OBS Medical delivers life-saving insight through its innovative clinical solutions for safer hospitals, safer patients and safer drugs. Based on intelligent algorithms such as neural networks, data fusion and waveform recognition, these technologies cover a range of medical applications including automated early crisis warning (Visensia(R)) and efficient cardiac safety for pharmaceutical research and development (BioQT(TM)). OBS Medical is in Carmel, Indiana and is a wholly-owned subsidiary of Oxford BioSignals Ltd. based in Oxford, UK, which was originally spun out from Oxford University.